Myriad Genetics, Inc. (MYGN) Social Stream
Myriad Genetics Inc (MYGN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Myriad Genetics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 22 months, MYGN's average price target has gone up $10.03.
Over the past 48 weeks, MYGN's average upside potential has been -6.81%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MYGN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 17 months, MYGN's average broker recommendation rating worsened by 0.2.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MYGN as an investment opportunity.
- In the context of Pharmaceutical Products stocks, Myriad Genetics Inc's upside potential (average analyst target price relative to current price) is greater than 28.43% of them.
- In terms of how Myriad Genetics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 18.79% of that group.
- In the context of stocks in the mid market cap category, Myriad Genetics Inc's average analyst price target is greater than 133.48% of them.
- In the context of stocks in the mid market cap category, Myriad Genetics Inc's number of analysts covering the stock is higher than 150% of them.
Is MYGN a Buy, Hold or Sell? See the POWR Ratings now!